| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q1 2022 Pre-Market | EPS: REV: | ||||
| Q4 2021 Pre-Market | EPS: REV: | ||||
| Q3 2021 Pre-Market | EPS: REV: | 0.61 16.713M | |||
| Q2 2021 Pre-Market | EPS: REV: | ||||
| Q1 2021 Pre-Market | EPS: REV: | 0.51 17.721M | 0.46 14.23M | 0.46 12.259M | 0% -13.85% |
| Q4 2020 Pre-Market | EPS: REV: | 0.66 16.195M | 0.51 15.34M | 0.45 14.416M | -11.76% -6.02% |
| Q3 2020 Pre-Market | EPS: REV: | 0.48 13.246M | 0.47 16.86M | 0.61 16.713M | 29.79% -0.87% |
| Q2 2020 Pre-Market | EPS: REV: | 0.43 12.935M | 0.23 12.47M | 0.36 15.003M | 56.52% 20.31% |
| Q1 2020 Pre-Market | EPS: REV: | 0.18 13.681M | 0.53 17.69M | 0.51 17.721M | -3.77% 0.18% |
| Q4 2019 Pre-Market | EPS: REV: | 0.18 12.961M | 0.45 18.74M | 0.66 16.195M | 46.67% -13.58% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
- The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
- Coinbase Analysts: Crypto Exchange Well Positioned to Continue Strong Growth Trajectory
- Mid-Afternoon Market Update: Dow Jumps 400 Points; CorMedix Shares Slide
- Dr Reddy's Rolls Out Sputnik V COVID-19 Vaccine In India At $13.58/Dose
- Why Gevo Stock Could See A Bullish Reversal In The Coming Weeks
- EXCLUSIVE: Vuzix CEO Talks Product Advantages, Next-Gen Smart Glasses
- DoorDash Stock Surges On Solid Revenue Beat: Here's What To Watch For
- Walt Disney Shares Pull Back After Q2 Earnings: What Do Analysts Think?
- Schneider Targets 60% Drop In CO2 Emissions Per Mile By 2035
